| Literature DB >> 31014231 |
Shi Yan1, Benjamin Jun Jie Seng1, Yu Heng Kwan1, Chuen Seng Tan2, Joanne Hui Min Quah3, Julian Thumboo4, Lian Leng Low5.
Abstract
BACKGROUND: Heterogeneity of population health needs and the resultant difficulty in health care resources planning are challenges faced by primary care systems globally. To address this challenge in population health management, it is critical to have a better understanding of primary care utilizers' heterogeneous health profiles. We aimed to segment a population of primary care utilizers into classes with unique disease patterns, and to report the 1 year follow up healthcare utilizations and all-cause mortality across the classes.Entities:
Keywords: Latent class analysis; Population segmentation; Primary care
Mesh:
Year: 2019 PMID: 31014231 PMCID: PMC6477732 DOI: 10.1186/s12875-019-0939-2
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Baseline demographics, clinical characteristics and healthcare utilization of patients in Year 2012
| Characteristics a | Class 1 | Class 2 | Class 3 | Class 4 | Class 5 | Class 6 | Overall | |
|---|---|---|---|---|---|---|---|---|
| Age, (SD) | 43.1 (15.0) | 62.1 (12.2) | 72.9 (11.1) | 54.2 (19.4) | 64.8 (11.5) | 70.6 (13.3) | 51.7 (17.4) | <0.001 |
| Gender | ||||||||
| Male, (%) | 25,979 (44.6) | 11,399 (43.3) | 1,620 (54.7) | 538 (48.7) | 5,392 (48.5) | 587 (56.7) | 45,515 (45.2) | <0.001 |
| Race | ||||||||
| Chinese, (%) | 42,890 (73.7) | 22,596 (85.9) | 2,468 (83.3) | 687 (62.2) | 8,971 (80.7) | 802 (77.5) | 78,414 (77.8) | <0.001 |
| Malay, (%) | 8.258 (14.2) | 1,635 (6.2) | 174 (5.9) | 208 (18.8) | 991 (8.9) | 116 (11.2) | 11,382 (11.3) | |
| Indian, (%) | 4,511 (7.8) | 1,520 (5.8) | 248 (8.4) | 171 (15.5) | 889 (8.0) | 91 (8.8) | 7,430 (7.4) | |
| Others, (%) | 2,554 (4.4) | 558 (2.1) | 74 (2.5) | 38 (3.4) | 271 (2.4) | 26 (2.5) | 3,521 (3.5) | |
| Social determinants of health | ||||||||
| Public rental housing, (%) | 4,406 (7.6) | 1,929 (7.3) | 401 (13.5) | 275 (24.9) | 949 (8.5) | 162 (15.7) | 8,122 (8.1) | |
| Comorbidities | ||||||||
| Type 2 Diabetes mellitus (%) | 451 (0.8) | 4,981 (18.9) | 1,592 (53.7) | 175 (15.9) | 11,122 (100) | 654 (63.2) | 18,975 (18.8) | <0.001 |
| Hypertension, (%) | 3,883 (6.7) | 19,099 (72.6) | 2,881 (97.2) | 432 (39.1) | 11,040 (99.3) | 970 (93.7) | 38,305 (38.0) | <0.001 |
| Hyperlipidemia, (%) | 2 (0.01) | 23,427 (89.1) | 2,809 (94.8) | 334 (30.3) | 11,060 (99.4) | 865 (83.6) | 38,497 (38.2) | <0.001 |
| Type 2 diabetes mellitus with complication, (%) | 23 (0.04) | 0 (0) | 103 (3.5) | 5 (0.5) | 1,586 (14.3) | 205 (19.8) | 1,922 (1.9) | <0.001 |
| Chronic kidney disease stage 3 and 4, (%) | 50 (0.1) | 945 (3.6) | 239 (8.1) | 12 (1.1) | 1,408 (12.7) | 1,035 (100) | 3,689 (3.7) | <0.001 |
| Chronic kidney disease stage 5, end stage renal disease, (%) | 0 (0) | 0 (0) | 0 (0) | 1 (0.1) | 0 (0) | 1,003 (96.9) | 1,004 (1.0) | <0.001 |
| Coronary artery disease, (%) | 198 (0.3) | 2,433 (9.3) | 2,485 (83.8) | 53 (4.8) | 1,954 (17.6) | 523 (50.5) | 7,646 (7.6) | <0.001 |
| Atrial fibrillation, (%) | 45 (0.1) | 99 (0.4) | 514 (17.3) | 20 (1.8) | 1 (0.01) | 139 (13.4) | 818 (0.8) | <0.001 |
| Heart failure, (%) | 88 (0.2) | 114 (0.4) | 863 (29.1) | 32 (2.9) | 15 (0.1) | 322 (31.1) | 1,434 (1.4) | <0.001 |
| Peripheral vascular disease, (%) | 24 (0.04) | 95 (0.4) | 372 (12.6) | 9 (0.8) | 132 (1.2) | 117 (11.3) | 749 (0.7) | <0.001 |
| Stroke, (%) | 145 (0.3) | 1,565 (6.0) | 1,232 (41.6) | 32 (2.9) | 819 (7.4) | 282 (27.3) | 4,075 (4.0) | <0.001 |
| Asthma, (%) | 1,774 (3.1) | 777 (3.0) | 423 (14.3) | 901 (81.6) | 314 (2.8) | 95 (9.2) | 4,284 (4.3) | <0.001 |
| Chronic obstructive pulmonary disease, (%) | 210 (0.4) | 99 (0.4) | 564 (19.0) | 1,096 (99.3) | 74 (0.7) | 144 (13.9) | 2,187 (2.2) | <0.001 |
| Depression, (%) | 1,112 (1.9) | 713 (2.7) | 195 (6.6) | 79 (7.2) | 64 (0.6) | 79 (7.6) | 2,242 (2.2) | <0.001 |
| Dementia, (%) | 17 (0.03) | 91 (0.4) | 135 (4.6) | 5 (0.5) | 56 (0.5) | 49 (4.7) | 353 (0.4) | <0.001 |
| Anxiety, (%) | 545 (0.9) | 361 (1.4) | 66 (2.2) | 31 (2.8) | 18 (0.2) | 21 (2.0) | 1,042 (1.0) | <0.001 |
| Osteoarthritis, (%) | 4,870 (8.4) | 7,716 (29.3) | 737 (24.9) | 220 (19.9) | 689 (6.2) | 288 (27.8) | 14,520 (14.4) | <0.001 |
| Benign prostate hyperplasia, (%) | 189 (0.3) | 454 (1.7) | 208 (7.0) | 18 (1.6) | 25 (0.2) | 27 (2.6) | 921 (0.9) | <0.001 |
| Hyperthyroidism, (%) | 526 (0.9) | 442 (1.7) | 33 (1.1) | 18 (1.6) | 19 (0.2) | 6 (0.6) | 1,044 (1.0) | <0.001 |
| Hypothyroidism, (%) | 453 (0.8) | 1,127 (4.3) | 98 (3.3) | 29 (2.6) | 87 (0.8) | 27 (2.6) | 1,821 (1.8) | <0.001 |
| Malignancy, (%) | 627 (1.1) | 1,137 (4.3) | 298 (10.1) | 79 (7.2) | 387 (3.5) | 91 (8.8) | 2,619 (2.6) | <0.001 |
| Metastatic disease, (%) | 90 (0.2) | 168 (0.6) | 56 (1.9) | 11 (1.0) | 12 (0.1) | 11 (1.1) | 348 (0.4) | <0.001 |
| Healthcare utilization in Year 2012 | ||||||||
| Number of primary care outpatient clinic visits, (SD) | 2.8 (4.0) | 5.7 (3.8) | 6.7 (5.7) | 5.6 (10.3) | 6.6 (4.5) | 6.5 (8.7) | 4.1 (4.6) | <0.001 |
| Number of outpatient specialist clinic visit, (SD) | 1.7 (4.3) | 2.8 (6.0) | 5.0 (7.8) | 4.2 (8.6) | 2.5 (5.4) | 10.0 (12.5) | 2.7 (5.4) | <0.001 |
| Number of hospital admission, (SD) | 0.1 (0.4) | 0.1 (0.5) | 0.5 (1.2) | 0.4 (0.9) | 0.1 (0.5) | 1.2 (1.8) | 0.1 (0.5) | <0.001 |
| Number of emergency department visits, (SD) | 0.1 (0.5) | 0.1 (0.5) | 0.2 (0.6) | 0.6 (1.5) | 0.2 (0.6) | 1.2 (1.9) | 0.2 (0.7) | <0.001 |
Abbreviations: SD standard deviation
aKruskal Wallis test or ANOVA test was used to compare healthcare utilization between the 6 classes while Chi-Square test was used to compare the mortality data among the classes
Criteria to assess model fit for latent class analysis models
| Number of Classes (k) | Class sizes | Akaike (AIC) | Bayesian (BIC) | Sample-Size Adjusted BIC |
|---|---|---|---|---|
| 2 | Class 1 = 65,012 (64.5%) | 672,123 | 672,551 | 672,409 |
| 3 | Class 1 = 64,813 (64.3%) | 662,674 | 663,321 | 663,105 |
| 4 | Class 1 = 64,091 (63.6%) | 658,999 | 659,866 | 659,576 |
| 5 | Class 1 = 61,792 (61.3%) | 656,030 | 657,115 | 656,753 |
| 6 | Class 1 = 58,213 (57.8%) | 653,089 | 654,394 | 653,958 |
Fig. 1Graphical display of comorbidities of patients by latent classes (k = 6)
Healthcare utilization patients in 2013 and one-year all-cause mortality (k = 6)
| Healthcare utilization / mortality a | Class 1 | Class 2 | Class 3 | Class 4 | Class 5 | Class 6 | Overall | |
|---|---|---|---|---|---|---|---|---|
| Number of primary care outpatient clinic visits, (SD) | 2.0 (3.9) | 5.3 (3.9) | 6.0 (5.5) | 4.7 (6.0) | 6.2 (4.2) | 4.9 (7.6) | 3.5 (4.4) | < 0.001 |
| Number of outpatient specialist clinic visit, (SD) | 1.6 (4.6) | 2.7 (5.9) | 4.7 (7.8) | 3.8 (7.5) | 2.6 (5.7) | 8.6 (11.9) | 2.2 (5.5) | < 0.001 |
| Number of hospital admission, (SD) | 0.1 (0.4) | 0.1 (0.5) | 0.5 (1.1) | 0.3 (0.9) | 0.1 (0.5) | 1.0 (1.7) | 0.1 (0.5) | < 0.001 |
| Number of emergency department visits, (SD) | 0.1 (0.5) | 0.1 (0.6) | 0.5 (1.8) | 0.6 (2.0) | 0.2 (0.6) | 1.0 (1.8) | 0.1 (0.7) | < 0.001 |
| One-year all-cause mortality | 179 (0.3) | 207 (0.8) | 139 (4.7) | 19 (1.7) | 125 (1.1) | 92 (8.9) | 761 (0.8) | < 0.001 |
Abbreviations: SD standard deviation
aKruskal Wallis test or ANOVA test was used to compare healthcare utilization between the 6 classes while Chi-Square test was used to compare the mortality data among the classes
Multivariable negative binomial regression on healthcare utilization and cox proportional hazards regression on mortality in Year 2013 (k = 6)
| Healthcare utilization or mortality a | IRR, unless otherwise specified | 95% Confidence interval | p-value |
|---|---|---|---|
| Number of primary care outpatient clinic visits | |||
| Class 1 | 1.00 |
| |
| Class 2 | 2.69 | 2.64–2.73 | < 0.001 |
| Class 3 | 3.20 | 3.08–3.32 | < 0.001 |
| Class 4 | 2.42 | 2.28–2.57 | < 0.001 |
| Class 5 | 3.16 | 3.09–3.22 | < 0.001 |
| Class 6 | 2.83 | 2.66–3.02 | < 0.001 |
| Number of outpatient specialist clinic visit | |||
| Class 1 | 1.00 |
| |
| Class 2 | 1.67 | 1.62–1.74 | < 0.001 |
| Class 3 | 3.33 | 3.07–3.62 | < 0.001 |
| Class 4 | 2.60 | 2.28–2.98 | < 0.001 |
| Class 5 | 1.68 | 1.60–1.76 | < 0.001 |
| Class 6 | 6.60 | 5.75–7.56 | < 0.001 |
| Number of hospital admission | |||
| Class 1 | 1.00 |
| |
| Class 2 | 1.75 | 1.64–1.86 | < 0.001 |
| Class 3 | 8.05 | 7.14–9.07 | < 0.001 |
| Class 4 | 4.79 | 3.93–5.83 | < 0.001 |
| Class 5 | 2.20 | 2.03–2.38 | < 0.001 |
| Class 6 | 19.68 | 16.41–23.61 | < 0.001 |
| Number of emergency department visits | |||
| Class 1 | 1.00 |
| |
| Class 2 | 1.66 | 1.57–1.75 | < 0.001 |
| Class 3 | 6.89 | 6.19–7.67 | < 0.001 |
| Class 4 | 6.68 | 5.65–7.89 | < 0.001 |
| Class 5 | 1.91 | 1.78–2.06 | < 0.001 |
| Class 6 | 13.86 | 11.74–16.37 | < 0.001 |
| One-year all-cause mortality b | |||
| Class 1 | 1.00 |
| |
| Class 2 | 2.81 | 2.59–3.04 | < 0.001 |
| Class 3 | 14.57 | 13.25–16.01 | < 0.001 |
| Class 4 | 7.03 | 5.86–8.42 | < 0.001 |
| Class 5 | 4.43 | 4.05–4.83 | < 0.001 |
| Class 6 | 27.97 | 25.01–31.29 | < 0.001 |
Abbreviations: IRR Incidence rate ratio (number of events divided by the person-time at risk)
a– Class 1: Relatively Healthy; Class 2: Stable metabolic disease, Class 3: Metabolic disease with vascular complications, Class 4: High respiratory burden, Class 5: High Metabolic disease without complication, Class 6: Metabolic disease with end-organ failure
b- Hazard ratio was reported
Models are adjusted for age, gender, and ethnicity. Survival time was used as exposure variable for negative binomial regression